Summary
Introduction:
This text presents the findings of a study examining the relationship between e-cigarette use and adverse respiratory symptoms in adolescents and young adults. The study aims to determine if the type of e-cigarette device used affects the likelihood of developing respiratory symptoms.
Key Points:
* The study included four populations of adolescents and young adults from California and Connecticut, with a total of 10,483 participants.
* Participants were asked about their use of e-cigarette devices, including pods, pens/tanks, disposables, and mods, and about any adverse respiratory symptoms they had experienced.
* The study found that e-cigarette use was associated with an increased likelihood of bronchitis symptoms and shortness of breath, but not with asthma exacerbations.
* among past 30-day e-cigarette users, there was no significant difference in the odds of reporting adverse respiratory symptoms based on the type of device used.
* The study controlled for potential confounding factors, such as age, gender, and use of other tobacco and cannabis products.
* The study used a cross-sectional design, which limits the ability to make causal inferences.
* The study's findings suggest that e-cigarette use may be associated with adverse respiratory symptoms, and that more frequent use may increase the risk.
Main Message:
The study provides evidence that e-cigarette use is associated with an increased likelihood of bronchitis symptoms and shortness of breath in adolescents and young adults. The study also suggests that the type of e-cigarette device used does not affect the likelihood of developing respiratory symptoms. These findings add to the growing body of evidence suggesting that e-cigarette use may have negative health consequences, and highlight the need for further research to better understand the risks associated with e-cigarette use.
Citation
Chaffee BW, Barrington-Trimis J, Liu F, et al. E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States. Preventive medicine. 2021;153:106766. doi:10.1016/j.ypmed.2021.106766
